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The importance of CD4 T lymphocytes in immunity to M. tuberculosis is well established; however,
how dendritic cells activate T cells in vivo remains obscure. In this issue of Cell Host & Microbe,
Srivastava and Ernst (2014) report a mechanism of antigen transfer for efficient activation of antimycobacte-
rial T cells.Due to their unique ability to activate naive
T lymphocytes, dendritic cells (DCs) play
a key part in immune response tomicrobi-
al pathogens and other injuries. In a
textbook scenario, DCs located in tissues
in a so-called immature stage are highly
phagocytic. After antigen capture and
stimulation by various danger signals,
including microbial molecular patterns,
DCs undergo amaturation process during
which they lose their phagocytic proper-
ties and acquire the ability to migrate
from the tissue to the draining lymph
node where they activate T lymphocytes
through antigen presentation by major
histocompatibility complex (MHC) mole-
cules and through the engagement
of costimulatory molecules (Steinman,
1991).
Mycobacterium tuberculosis, the etio-
logic agent of tuberculosis, triggers a
similar scenario (for review, see O’Garra
et al., 2013; Philips and Ernst, 2012).
Indeed, the migration of M. tuberculosis-
infected DCs from the lungs to the medi-
astinal lymph node has been shown to
be a key step in activation of IFN-g-pro-
ducing CD4+ T (TH1) lymphocytes. TH1
cells are players in controllingmycobacte-
rial dissemination by stimulating the mi-
crobicidal properties of pulmonarymacro-
phages. This is well illustrated by the facts
that (1) MHC-II- or IFN-g-deficient mice
rapidly succumb after M. tuberculosis
infection, and (2) in humans, immune-
compromised individuals with low CD4+
T lymphocytes, such as AIDS patients,
are also highly susceptible to the bacillus.
Very strikingly,M. tuberculosis is known to
impair antigen presentation by DCs
in vitro, raising the intriguing question of
how M. tuberculosis-infected DCs can
induce a strong antimycobacterial TH1
response in vivo.In the current issue of Cell Host &
Microbe, Srivastava and Ernst provide
compelling evidence that although
M. tuberculosis-infected DCs are poor
antigen presenters in vivo, these cells
manage to induce a strong activation of
CD4+ T cells by transferring intact myco-
bacterial antigens to more powerful unin-
fected bystander DCs residing in the
draining lymph node. The notion that anti-
gen collection and presentation and T cell
activation can be performed through
collaboration between various DCs is not
new per se (Davis, 2007; Wakim and
Bevan, 2011). Indeed, in recent years an-
tigen transfer between DCs stimulated in
tissues and DCs residing in lymph nodes
has been increasingly recognized as a
keymechanism for the induction of immu-
nity or the establishment of T cell memory
response, for instance (Davis, 2007;
Wakim and Bevan, 2011). The article by
Srivastava and Ernst (2014) highlights
two key points: (1) it confirms and
builds upon the notion that antigen trans-
fer between DCs is instrumental to
overcome the impaired antigen presenta-
tion capacity of M. tuberculosis-infected
DCs; (2) even more importantly, it
identifies an original pathway whereby
infected DCs release unprocessed myco-
bacterial antigens for uptake and presen-
tation by noninfected resident DCs in the
lymph node (Figure 1).
The notion that antigen transfer is
involved in the induction of T cell immunity
to M. tuberculosis was previously recog-
nized (Samstein et al., 2013). In the study
by Srivastava and Ernst, this concept is
elegantly reported using intratracheal
adoptive transfer of M. tuberculosis-
infected DCs displaying, or not, MHC
class II into uninfected, MHC-II-compe-
tent or -deficient mice. In order to readilyCell Host & Microbedetect T cell activation in vivo, the authors
transferred naive CD4+ T cells originating
from two different mouse models trans-
genic for T cell receptors specific for
two independent mycobacterial antigens.
Combined with strategies aiming at
interfering with DC migration, these
experiments clearly demonstrated the
cooperation of locally M. tuberculosis-
infected DCs and noninfected resident
DCs in initiating CD4+ T cell responses in
the lymph node.
In their study, Srivastava and Ernst paid
much attention to the process involved
in antigen transfer and convincingly
reported that the antigens had to come
from M. tuberculosis-infected DCs and
not from isolated mycobacteria. This
conclusion was reached not only by
recusing the role of extracellular myco-
bacteria in driving CD4+ T cell activation
in the lymph node, but also by providing
direct evidence for an unsuspected
mechanism involving the release ofmyco-
bacterial antigens by infected DCs and
their subsequent uptake by lymph node
DCs. Interestingly, using M. tuberculosis
mutants impaired in their ability to induce
DC apoptosis as well as by using
vesicles purified from the supernatant of
M. tuberculosis-infected DCs, the authors
found that antigen transfer did not involve
the release of vesicles such as exosomes
or apoptotic bodies from the infected
cells. Strikingly, this mechanism relies on
the uptake of unprocessed mycobacterial
antigens secreted by infected DCs by
lymph node resident DCs. Not only could
full-length mycobacterial antigens be
identified in the culture supernatant of
infected DCs, but those supernatants
were also able to recapitulate T cell acti-
vation by resident, noninfected DCs.
Although the exact mechanism whereby15, June 11, 2014 ª2014 Elsevier Inc. 657
Figure 1. The Role of Antigen Transfer from Infected DCs to Uninfected DCs in the Activation of Antimycobacterial CD4+ T Cells
M. tuberculosis is phagocytosed by immature DCs in the lung. Infected DCs mature and migrate to the draining mediastinal lymph node, where they poorly
present antigens to CD4+ T cells. In the lymph node, infected DCs secrete unprocessed mycobacterial antigens that are captured, processed, and presented
to CD4+ T lymphocytes by resident DCs, which stimulates T cell proliferation.
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infected DCs is unknown, it was reported
to happen for several proteins secreted by
the ESX-1 or ESX-3 type VII secretion
systems. This result suggests that antigen
transfer between DCs might be limited
to secreted mycobacterial antigens, but
further studies are necessary to directly
address this issue.
This mechanism seems markedly
different from a recently described mech-
anism in which antigens transferred via
gap junctions from macrophages and
DCs play a central role in oral tolerance
(Mazzini et al., 2014). Interestingly, the
transfer of preformed peptide-MHC com-
plexes from infected to donor DCs via the
process of trogocytosis, a previously
describedmechanism of T cell stimulation658 Cell Host & Microbe 15, June 11, 2014 ª(Joly and Hudrisier, 2003; Wakim and
Bevan, 2011), also does not seem to be
at work in the context of M. tuberculosis
infection. Trogocytosis requires effi-
cient generation of peptide-MHC com-
plexes by infected DCs; however,
M. tuberculosis infection results in poor
antigen presentation by infected DCs.
Thus, the mechanism identified in the
study by Srivastava and Ernst might
reflect an adaptation of our immune
system to overcome the limited direct
antigen presentation capacity of DCs
infected by M. tuberculosis, and possibly
other intracellular pathogens, through
some sort of task sharing among DCs,
where unprocessed antigens (or pos-
sibly close to full-length proteolytically
generated intermediates) are delivered2014 Elsevier Inc.by antigen presentation-incompetent
DCs to antigen presentation-competent
DCs. The cellular and molecular dissec-
tion of this intriguing mechanism of anti-
gen secretion and transfer opens new
research venues in the fields of microbi-
ology, immunology, and cell biology.
Whether this mechanism contributes to
the delay in T cell activation (Ernst, 2012;
O’Garra et al., 2013) or to the quality of
T cell responses in tuberculosis will need
to be explored.
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Two reports in this issue of Cell Host & Microbe establish that Nod-like receptor proteins NOD1 and NOD2
regulate stem cell function. Burberry et al. (2014) demonstrate that NOD1 and NOD2 synergize with TLRs
to mobilize hematopoietic stem cells. Nigro et al. (2014) report that NOD2 provides cytoprotection to intes-
tinal stem cells.The host-encoded pattern-recognition
molecules (PRMs) nucleotide-binding
oligomerization domain 1 (NOD1, also
referred to as NRLC1) and NOD2
(NLRC2), which belong to the Nod-like re-
ceptor (NLR) protein family, are known to
sense distinct bacterial peptidoglycan
(PGN) fragments derived from pathogens,
commensals, and pathobionts to instruct
innate and adaptive antimicrobial immu-
nity and regulate mucosal immune ho-
meostasis (Fritz et al., 2006). Now, two
recent reports from Nigro et al. (2014)
and Burberry et al. (2014) published in
this issue of Cell Host & Microbe extend
our knowledge of how these NLR proteins
instruct immunity by demonstrating that
PGN sensing by NOD1 and NOD2 regu-
late key biological functions of hemato-
poietic stem cells (HSCs) and intestinal
stem cells (Figure 1).
During infection and inflammation, im-
mune cells are in high demand and are
quickly consumed at the sites of need.
While adaptive immune cells have high
proliferative capacity, innate immune cells
are mostly postmitotic and need to be
rapidly replenished from bone marrow(BM) hematopoietic stem and progenitor
cells. It is estimated that in an adult hu-
man, 3 3 105 erythrocytes and 3 3 104
white blood cells are produced per sec-
ond at steady state, and upon infectious
challenge the cellular production can in-
crease several-fold over baseline levels.
Obviously, such high cellular throughput
requires a tight hierarchical control that
is organized with the HSCs at the top.
The majority of HSCs reside in the BM
within the stem cell niche, while a smaller
subset of HSCs reside in the spleen and
serve as a site for hematopoiesis during
embryogenesis and periods of duress.
Although niche support is essential for
their maintenance, HSCs traffic through
the bloodstream and through peripheral
tissues and have the potential to serve
as a local source for cell production.
While much is known about HSC regu-
lation and activity under homeostatic con-
ditions, how HSC throughput is regulated
during infection and inflammation and
the contributions of distinct PRMs is less
clear. Recent work utilizing Toll-like
receptor (TLR)-deficient settings and
application of purified TLR agonists hasprovided evidence that indirect as well
as direct activation of HSCs by TLR ago-
nists is critical for demand-adapted he-
matopoiesis during microbial encounter
(Takizawa et al., 2012). In settings of
systemic infection, microbe-associated
molecular patterns (MAMPs) activating
TLR signaling are elevated in circulation
and reach the BM, where they directly
act on TLR-expressing HSCs and instruct
enhanced generation of a lineage on de-
mand. Upon encounter of invading patho-
gens in peripheral tissues, microbe-medi-
ated triggering of TLR on HSCs induces
migration arrest and promotes HSC
proliferation and differentiation to ensure
local supply of myeloid effector cells. Dur-
ing the course of an immune response,
when certain lineages are in high demand
at specific sites, TLR ligation on lineage-
committed progenitors in the BM is
thought to cause mobilization from the
BM and recruitment to these sites,
where they proliferate and differentiate in
response to local pathogens to replenish
immune effector cells (Ya´n˜ez et al., 2013).
As Escherichia coli is commonly iso-
lated from the blood of humans suffering15, June 11, 2014 ª2014 Elsevier Inc. 659
